Abstract:Abstract Background Coronavirus disease 2019 (COVID-19) is a novel infectious viral disease, which lacks well-established diagnostic laboratory parameters that could be used to evaluate disease severity, thromboembolism or cardiovascular events and to predict clinical prognosis. Coagulation cascade and platelet functions have not been well studied in the COVID-19 patients. Methods A total of 178 patients enrolled in Wuhan Huoshenshan Hospital were included for the study. Blood platelets and coagulation functions were analyzed in COVID-19 patients with non-severe and severe subgroups. Other biochemical laboratory parameters were also analyzed. Results Forty-nine (27.5%) out of 178 patients were diagnosed with severe disease in this study, and 129 patients with non-severe disease. Severe disease group had significant lower platelet count 186.00 (103.50–249.00) ×109/L than 251.00 (202.00–317.00) ×109/L of non-severe group, p = 0.000. Severe group also had significantly abnormal coagulation parameters than non-severe group: prothrombin time (PT) 14.55 (13.40–16.53) s vs. 12.70 (12.15–13.59) s, p = 0.000; international normalized ratio (INR) 1.21 (1.13–1.36) vs. 1.06 (1.01–1.13), p = 0.000; thrombin time (TT) 16.35 (15.69–17.47) s vs. 15.68 (14.79–16.69) s, p = 0.011; D-Dimer 1.05 (0.68–5.90) mg/L vs. 0.42 (0.28–0.79) mg/L, p = 0.000; While the liver function parameter alanine aminotransferase (ALT) and aspartate aminotransferase (AST) didn’t show significance between two groups, ALT 30.80 (19.00–58.30) IU/L vs. 28.80 (15.75–50.15) IU/L, p = 0.487; AST 27.80 (19.30–40.55) IU/L vs. 22.6 (16.7–32.03) IU/L, p = 0.102. Disseminated intravascular coagulation (DIC) rate was 6.1% in severe group while 0% in non-severe group. Survival rate of severe disease group was worse than non-severe group, 85.7% vs. 100%, p = 0.000. Thrombocytopenia correlated with coagulation function, DIC rate and survival. Six out of 7 death case had thrombocytopenia during hospitalization, and platelet count decreased subsequently until death. Thrombocytopenia occurred within 1 week after admission in 6 recovered patients. And increased platelet levels followed by positive SARS-CoV-2 IgM/IgG and negative coronavirus nucleic acid tested in 8 recovered patients. Conclusions Low platelet count is associated with abnormal coagulation function and increased risk of DIC, severe disease manifestation and increased mortality in patients with COVID-19.

COVID‐19 coagulopathy: An in‐depth analysis of the coagulation system

SARS-CoV-2 Induced Thrombocytopenia As an Important Biomarker Significantly Correlated with Abnormal Coagulation Function, Increased Intravascular Blood Clot Risk and Mortality in COVID-19 Patients

Coagulation Dysfunction In Icu Patients With Coronavirus Disease 2019 In Wuhan, China: A Retrospective Observational Study Of 75 Fatal Cases

A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients

Characteristics of coagulation alteration in patients with COVID-19

Association of coagulation disturbances with severity of COVID-19: a longitudinal study

Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study

Dynamic changes in coagulation parameters and correlation with disease severity and mortality in patients with COVID-19

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Coagulopathy in patients with Coronavirus Disease 2019（COVID-19）：a systemetic review and meta-analysis

Clinical Characteristics and Risk Factors of Disseminated Intravascular Coagulation in Patients with COVID-19

Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis

Coagulation dysfunction is associated with severity of COVID‐19: A meta‐analysis

Coagulopathy in patients with COVID-19: a systematic review and meta-analysis

Analysis of Coagulation Profile and Possible Mechanism of Coagulation Activation in COVID-19 Patients: A Systematic Literature Review

Common Coagulopathies Associated With COVID-19 Patients

Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19

DIC in COVID-19

Understanding COVID-19-associated coagulopathy: From PIC to SIC or DIC

Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis

The values of coagulation function in COVID-19 patients